Blog

Scientific American custom media and Immunomic Therapeutics, Inc. wrote this article titled, “After the Gold Rush." Immuno-oncology (IO) has seen a flood of advancements, investment deals and partnerships, but the

May is Brain Tumor Awareness Month. In the United States, an estimated 700,000 people are living with a primary brain tumor and 79,000 more will be diagnosed this year. Gliomas

Sia Anagnostou, Senior Director at Immunomic Therapeutics authored this article, "Md. is developing the next generation of life-saving vaccines" in the Baltimore Sun. http://www.baltimoresun.com/news/opinion/oped/bs-ed-op-1020-vaccines-md-20171018-story.html  

A closer look at the social, cultural and political issues influencing immunization This article was produced for Immunomic Therapeutics by Scientific American Custom Media, a division separate from the magazine’s board of editors.

August is National Immunization Awareness Month and Rockville, MD based Immunomic Therapeutics is dedicated to raising awareness of the importance of receiving life-saving vaccines. Vaccines are recommended to people of

On June 13, Immunomic Therapeutics Inc. (ITI) participated in the “Making a Name in Cancer Immunotherapy” webcast, hosted by Nature.com. Other participating companies included Isoplexis, Merus, and Actinium Pharmaceuticals, Inc.

Immunomic Therapeutics Inc. is looking forward to attending the annual BIO Convention in San Diego, California next week. The International BIO Convention brings together nearly 16,000 innovators and researchers from

Sunday, June 4, 2017, is National Cancer Survivors Day and we are celebrating those who have defeated cancer and supporting patients who are currently fighting the disease. Over the past

By Colin Magowan A new interest has emerged on the CD4+ helper T cell and its role in anti-tumor responses. This renewed focus on the importance of this cell population

May is Brain Cancer Awareness Month and Rockville, MD based Immunomic is dedicated to raising awareness and advancing research for this devastating cancer. The facts are grim, over 700,000 Americans

This month, we are celebrating Allergy and Asthma Awareness Month. May is peak season for allergy and asthma sufferers and we want to help raise awareness about the dangers of

Midissia Therapeutics to Develop Immune Intensification Technology at Immunomic Labs Last night, Immunomic Therapeutics announced the winner of their Cancer Discovery Incubator Award: Midissia Therapeutics (Midissia). Midissia is a clinical